This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 1993 Jan 16;341(8838):153-4.

doi: 10.1016/0140-6736(93)90011-5.

Ivermectin and onchocercal optic nerve lesions

D Mabey

PMID: 8093751
DOI: 10.1016/0140-6736(93)90011-5

Comment

Ivermectin and onchocercal optic nerve lesions

D Mabey. Lancet. 1993.

. 1993 Jan 16;341(8838):153-4.

doi: 10.1016/0140-6736(93)90011-5.

Author

D Mabey

PMID: 8093751
DOI: 10.1016/0140-6736(93)90011-5

No abstract available

PubMed Disclaimer

Comment in

Supply of ivermectin in developing countries.
Van Damme W. Van Damme W. Lancet. 1993 Mar 6;341(8845):634-5. doi: 10.1016/0140-6736(93)90397-y. Lancet. 1993. PMID: 8094862 No abstract available.

Comment on

Reduction in incidence of optic nerve disease with annual ivermectin to control onchocerciasis.
Abiose A, Jones BR, Cousens SN, Murdoch I, Cassels-Brown A, Babalola OE, Alexander ND, Nuhu I, Evans J, Ibrahim UF, et al. Abiose A, et al. Lancet. 1993 Jan 16;341(8838):130-4. doi: 10.1016/0140-6736(93)90002-x. Lancet. 1993. PMID: 8093742 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions

LinkOut - more resources

Full Text Sources
- Elsevier Science
- Ovid Technologies, Inc.
Medical
- MedlinePlus Health Information